Alendronic acid
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Alendronic acid and local guidelines before prescribing.
Mechanism
Bisphosphonate that binds bone and inhibits osteoclast-mediated resorption.
Uses
Osteoporosis prevention and treatment, including glucocorticoid-induced.
Dosing
- Treat bone pain from active Paget's with a bisphosphonate. Zoledronic acid 5 mg IV as a single infusion is most effective, often giving years of remission. Ensure vitamin D is replete beforehand. Alternatives are oral risedronate or alendronate.
Endocrinology: Bone Medicine - Alendronic acid (osteoporosis) | 70 mg orally once weekly. Take fasting with a full glass of water and stay upright for 30 minutes. Avoid if CrCl is below 35 mL/min or with oesophageal disease.
Endocrinology: Bone Medicine
Side effects
Oesophagitis, dyspepsia, abdominal pain, musculoskeletal pain; rarely osteonecrosis of the jaw and atypical femoral fracture.
Interactions
Calcium, antacids and food reduce absorption; NSAIDs increase GI irritation.
Contraindications and cautions
Oesophageal abnormalities, inability to sit upright for 30 minutes, hypocalcaemia, eGFR below 35
Monitoring
Calcium and vitamin D, dental health, renal function
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Avoid if eGFR below 35
Overdose and reversal
Give milk or antacid; do not induce vomiting
Special advice
Take fasting with a full glass of water, upright for at least 30 minutes; correct calcium and vitamin D; dental check; avoid if oesophageal disorder or low eGFR below threshold.
More from the textbook: uses, cautions and other points
- Avoid if eGFR is under 35 (alendronate). Review the need after 5 years (consider a drug holiday).
Endocrine: Anatomy Physiology and Pharmacology - Alendronic acid | Upright 30 min with water; oesophagitis, jaw osteonecrosis, atypical femoral fractures.
Endocrine: Anatomy Physiology and Pharmacology - High risk: Oral bisphosphonate (alendronic acid or risedronate) first-line. If not tolerated, unsuitable or ineffective: IV zoledronic acid or denosumab. HRT is an option in younger postmenopausal women.
Endocrinology: Bone Medicine - 💡 Clinical Pearl: Many "treatment failures" on alendronate are actually taking it wrongly - with breakfast, tea or calcium. Check how the patient takes it before switching.
Endocrinology: Bone Medicine - Bisphosphonates — alendronic acid (weekly), risedronate, IV zoledronic acid (yearly) | Bind hydroxyapatite; taken up by osteoclasts → inhibit farnesyl pyrophosphate synthase → osteoclast apoptosis — anti-resorptive | Oral — take fasting with a full glass of water, sit upright 30 minutes ( oesophagitis ); avoid if eGFR under 35; …
Rheumatology Anatomy Physiology Pharmacology - Thigh pain and transverse femoral fracture after 8 years of alendronate | Atypical femoral fracture
Rheumatology Anatomy Physiology Pharmacology
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (3 mentions)
- Endocrinology: Bone Medicine (12 mentions)
- Rheumatology Anatomy Physiology Pharmacology (2 mentions)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Medicine of the older adult.: Falls, syncope, mobility and fragility fractures (3 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)